|
Q3 FY2019
As of May 31, 2019
|
Q2 FY2019
As of Feb 28, 2019
|
Q1 FY2019
As of Nov 30, 2018
|
Q4 FY2018
As of Aug 31, 2018
|
Q3 FY2018
As of May 31, 2018
|
Q2 FY2018
As of Feb 28, 2018
|
Q4 FY2017
As of Aug 31, 2017
|
Q3 FY2017
As of May 31, 2017
|
Q2 FY2017
As of Feb 28, 2017
|
Q1 FY2017
As of Nov 30, 2016
|
Q4 FY2016
As of Aug 31, 2016
|
Q3 FY2016
As of May 31, 2016
|
Q2 FY2016
As of Feb 29, 2016
|
Q1 FY2016
As of Nov 30, 2015
|
Q4 FY2015
As of Aug 31, 2015
|
Q3 FY2015
As of May 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Current assets | ||||||||||||||||
| Cash | ||||||||||||||||
| Accounts receivable | ||||||||||||||||
| Prepaid inventory | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||
| Current assets of discontinued operation | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net - discontinued operation | ||||||||||||||||
| Total assets | ||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||
| Current liabilities | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Notes payable - related party | ||||||||||||||||
| Accrued payroll expenses | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Deferred revenue | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Due to former officer | ||||||||||||||||
| Convertible note payable, net of discount | ||||||||||||||||
| Derivative liabilities | ||||||||||||||||
| Current liabilities of discontinued operation | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Long term convertible debenture, net of discount of $-0- and $46,559, respectively | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Stockholders' equity (deficit): | ||||||||||||||||
| Preferred stock par value $.0001: 10,000,000 shares authorized; no shares issued and outstanding | ||||||||||||||||
| Common stock par value $.0001: 2,490,000,000 shares authorized; 82,646,606 and 10,107,394 shares issued and outstanding as of May 31, 2019 and August 31, 2018, respectively | ||||||||||||||||
| Additional paid in capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Accumulated other comprehensive loss - discontinued operation | ||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||
| Total liabilities and stockholders' equity (deficit) | ||||||||||||||||
Loading...
